December 1, 2018
This article first appeared in European Pharmaceutical Manufacturer The pharmaceutical industry is undergoing a period of rapid change. Merger and acquisition activity is high, regulations are becoming more stringent, and companies are forced to be evermore focused on cost. Regulation challenges were recently made more complex by the introduction of ...
Pharmaceutical operations involve relationships with a mix of external stakeholders, which are typically defined by contracts--none more so than R&D.